Comparison of the Efficacy and Safety of Insulin Detemir Administered Once Daily According to Two Titration Algorithms (3-0-3 and 2-4-6-8) in Patients with Type 2 Diabetes Mellitus
Endocrinology and Metabolism
;
: 142-148, 2020.
Article
in English
| WPRIM
| ID: wpr-816619
ABSTRACT
BACKGROUND:
This study was conducted to compare glycaemic control with insulin detemir administered according to two titration algorithms (3-0-3 and 2-4-6-8) after 20 weeks of treatment in subjects with type 2 diabetes mellitus inadequately controlled on metformin.METHODS:
This was a 20-week, randomised, multicentre, open-labelled, treat-to-target trial. Forty-six patients were randomised in a 11 manner to either the 3-0-3 (G3, n=23) or 2-4-6-8 (G2, n=23) algorithm. The primary endpoint was change of haemoglobin A1c (HbA1c), and the secondary safety endpoint included hypoglycaemic events.RESULTS:
After 20 weeks, HbA1c decreased similarly in the G3 and G2 groups, with a mean change of −0.9% from baseline. The mean change in fasting plasma glucose was numerically similar in both groups. The hypoglycaemia event rate per 100-patient-years of exposure (r) in the G2 group (r=1,427) was higher than that in the G3 group (r=807).CONCLUSION:
Both treatment groups had numerically similar HbA1c reductions. A trend towards fewer hypoglycaemia episodes after dose stabilisation was seen with the simpler G3. Clinically, this may be an important observation, as a simpler titration algorithm may support self-management and maintenance of insulin therapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Self Care
/
Blood Glucose
/
Fasting
/
Diabetes Mellitus, Type 2
/
Insulin Detemir
/
Hyperglycemia
/
Insulin
/
Metformin
Type of study:
Controlled clinical trial
Limits:
Humans
Language:
English
Journal:
Endocrinology and Metabolism
Year:
2020
Type:
Article
Similar
MEDLINE
...
LILACS
LIS